University of Alberta

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Hepalys Partners With Inventiva In

Germany’s BI Licenses Tumor-Specific Antibodies From Singapore Lab Boehringer Ingelheim GmbH and Singapore’s Agency for Science, Technology and Research (A*STAR) unveiled a global licensing agreem

Jonathan Behr, a US partner at the Dementia Discovery Fund (DDF), sees the increase during the past few years in early-stage investments in neurodegeneration-focused biopharmaceutical companies having

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Tonix Li